Precigen, Inc. (PGEN) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
PGEN Q1 2026: Paximius Revenue Jumps 535% as Community Uptake Drives Launch Acceleration
May 14, 2026
-
PGEN Q4 2025: Pepsimios Launch Drives 149% Revenue Surge, RRP Market Adoption Accelerates
March 26, 2026
-
PGEN Q3 2025: Pepsimus Launch Engages 90% of Target Centers, Igniting Rare Disease Uptake Cycle
November 14, 2025